CTI: acquisition of Dynakin
CTI Clinical Trial and Consulting Services (CTI), a global CRO, has acquired European CRO Dynakin. The acquiring company plans to merge Dynakin’s CRO services into CTI’s European clinical team.
Timothy Schroeder, CTI’s chairman and CEO, said, “Dynakin and CTI share common philosophies and cultures, with a focus on teamwork, employee retention and career development. We are passionate about continued growth and expansion for the continued success of the company, so this acquisition is a great fit for the next phase of growth at CTI.”